Is Colorado's Cannabis Market Back On Track? A 5% Sales Boost Says Yes The Colorado Department of Revenue reported 673 cannabis dispensaries by the end of August, with an average revenue of $ ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Prime Medicine wasn’t one of them. The 10 stocks that made the ...

Stock prices may also move more quickly in this environment. Investors who anticipate trading during these times are strongly advised to use limit orders. Real-time Data is provided using Nasdaq ...

On the financial front, Disc Medicine announced a public stock offering of approximately $178 million, led by Frazier Life Sciences and Logos Capital, to advance research and clinical development ...

Editas Medicine, Inc. (NASDAQ: EDIT) incurred a loss of 82 cents per share in the second quarter of 2024, wider than the Zacks Consensus Estimate of a loss of 69 cents. The company had reported a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

A class II risk level is given to products that "may cause temporary or medically reversible adverse health consequences." ...

We know a company makes its own luck, but how many times can the fast-growing Telix Pharmaceuticals (ASX:TLX) be hit on the ...

In this article, we are going to take a look at where Editas Medicine, Inc. (NASDAQ ... we can outperform the market by imitating the top stock picks of the best hedge funds.

Experts have issued a warning after a woman lost her hair following an insect bite. The 28-year-old, from Boston, ...

However, the stock pulled back and was down 0.7% at 9:34 am Eastern time. Net income was $2.694 billion, or $1.11 a share, down from $4.309 billion, or $1.69 a share, in the prior year’s quarter ...

Prioritizing Set of High Value Programs in Core Areas of Focus; Modularity of Prime Editing Platform Expected to Allow Prime Medicine to Generate Follow-on Candidates Rapidly and ...